Form 4: ZUU Co. Ltd. Reports Changes in Beneficial Ownership of SBC Medical Group Holdings Inc.
SEC Form 4
ZUU Co. Ltd. and related entities report transactions involving SBC Medical Group Holdings Inc. common stock and warrants, including a transfer of shares and a sale of shares at a weighted average price.
Summary
- ZUU Co. Ltd., along with ZUU Funders Co. Ltd., ZUU Target Fund for SBC Medical Group HD Investment Partnership, and Kazumasa Tomita, filed a Form 4 detailing changes in beneficial ownership of SBC Medical Group Holdings Inc. securities.
- On September 17, 2024, 1,503,473 shares of common stock were transferred pursuant to a Non-Redemption Agreement.
- On September 19, 2024, 6,196 shares of common stock were sold at a weighted average price ranging from $7.00 to $8.47.
- The reporting persons may be deemed to have acquired 80,454 units, each consisting of one share of common stock and one redeemable warrant, with each warrant entitling the holder to purchase one share of common stock for $11.50 per share.
- The filing indicates indirect beneficial ownership of securities held by ZUU Funders Co. Ltd. and Second ZUU Target Fund for SBC Medical Group HD Investment Partnership.
- The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing changes in ownership. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Effective date of the registration statement on Form S-1 for the issuer's initial public offering. |
| January 11, 2024 | Date of the Non-Redemption Agreement among ZUU Target Fund, SBC Medical Group Holdings Incorporated, and Yoshiyuki Aikawa. |
| September 17, 2024 | Date of transfer of 1,503,473 shares of common stock and completion of the issuer's initial business combination. |
| September 19, 2024 | Date of sale of 6,196 shares of common stock. |
| October 17, 2024 | Warrants become exercisable 30 days after the completion of the issuer's initial business combination. |
| September 17, 2029 | Expiration date of warrants to purchase Common Stock at $11.50. |
| September 17, 2034 | Expiration date of warrants to purchase Common Stock at $0.01. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.